Ibuprofen efficacy, tolerability and safety in obese children: a systematic review

Eman Shamsaee1, Alaw Huws2, Andrea Gill3

  • 1Hull University Teaching Hospitals NHS Trust, Hull, UK.

Insights

Limited data exists on ibuprofen efficacy in obese children. One study showed adequate pain control with a 5 mg/kg dose, but more research is needed for dosing and adverse effects in this population.

Area of Science:

  • Pharmacology
  • Pediatrics
  • Drug Efficacy

Background:

  • Childhood obesity can alter drug disposition, potentially affecting the efficacy of common medications like ibuprofen.
  • There is a need to understand how ibuprofen works in obese children to ensure effective treatment.

Approach:

  • A systematic review was conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
  • Searches across 12 databases identified 1305 studies; four met inclusion criteria.
  • Two reviewers assessed study eligibility and quality.

Key Points:

  • Four studies (three retrospective cohort, one case study) involving overweight/obese children under 18 were included.
  • Dosing regimens varied, including weight-based (5 mg/kg), age-based, and adjusted body weight.
  • One study indicated adequate pain control with 5 mg/kg ibuprofen in obese children, while others did not compare efficacy between obese and non-obese groups.
  • An increased risk of bleeding was noted, but not specifically linked to obesity.

Conclusions:

  • Published data guiding ibuprofen prescribing in obese children is scarce.
  • Further research is required to establish optimal dosing and safety profiles for ibuprofen in pediatric obesity.
Abstract

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
290
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
581
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
169
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.1K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
157
Bioequivalence: Overview01:16

Bioequivalence: Overview

Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.2K